GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Illumina ILMN · USD

Health Care · US listing · 🇺🇸 United States

S&P 500

Compare

220.78

+3.59%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$4.34bn

FY2016FY2025

Net income

$850.0m

FY2016FY2025

Free cash flow

$931.0m

FY2016FY2025

Shareholders' equity

$2.72bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$4.34bn$4.37bn$4.50bn$4.58bn$4.53bn$3.24bn$3.54bn$3.33bn$2.75bn$2.40bn
Gross profit$2.89bn$2.86bn$2.74bn$2.97bn$3.15bn$2.20bn$2.47bn$2.30bn$1.83bn$1.67bn
Research and development$951.0m$1.17bn$1.35bn$1.32bn$1.19bn$682.0m$647.0m$623.0m$546.0m$504.4m
Operating income$864.0m−$833.0m−$1.07bn−$4.18bn−$123.0m$393.0m$985.0m$883.0m$606.0m$587.0m
Net income$850.0m−$1.22bn−$1.16bn−$4.40bn$762.0m$656.0m$1.00bn$826.0m$726.0m$462.6m
Diluted earnings per share5.52-7.64-7.30-27.874.854.466.775.544.913.13

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$6.64bn$6.30bn$10.11bn$12.25bn$15.22bn$7.58bn$7.32bn$6.96bn$5.26bn$4.28bn
Cash and short-term investments$1.63bn$1.22bn$1.05bn$2.04bn$1.34bn$3.47bn$3.41bn$3.51bn$2.15bn$1.56bn
Total liabilities$3.92bn$3.93bn$4.37bn$5.65bn$4.48bn$2.89bn$2.70bn$3.05bn$2.29bn$1.97bn
Debt$2.07bn$2.07bn$1.49bn$2.81bn$1.77bn$1.24bn$1.19bn$2.00bn$1.19bn$1.05bn
Shareholders' equity$2.72bn$2.37bn$5.75bn$6.60bn$10.74bn$4.69bn$4.61bn$3.85bn$2.84bn$2.27bn
Shares outstanding154m160m159m158m157m147m148m149m148m148m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$1.08bn$837.0m$478.0m$392.0m$545.0m$1.08bn$1.05bn$1.14bn$875.0m$687.2m
Capital spending−$148.0m−$128.0m−$195.0m−$286.0m−$208.0m−$189.0m−$209.0m−$296.0m−$312.0m−$271.4m
Free cash flow$931.0m$709.0m$283.0m$106.0m$337.0m$891.0m$842.0m$846.0m$563.0m$415.9m
Dividends paid———−$937.0m−$511.0m——−$735.0m−$5.0m−$11.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$1.16bn$1.09bn$1.16bn$1.08bn$1.06bn$1.04bn$1.10bn$1.08bn
Gross profit$770.0m$721.0m$759.0m$733.0m$718.0m$683.0m$728.0m$745.0m
Operating income$245.0m$209.0m$215.0m$229.0m$244.0m$193.0m$209.0m$259.0m
Net income$207.0m$134.0m$334.0m$150.0m$235.0m$131.0m$187.0m$705.0m
Diluted earnings per share1.350.882.180.971.500.821.184.41
Cash from operations$201.0m$289.0m$321.0m$284.0m$234.0m$240.0m$364.0m$316.0m
Capital spending−$40.0m−$38.0m−$54.0m−$24.0m−$23.0m−$39.0m−$29.0m−$32.0m
Free cash flow$161.0m$251.0m$267.0m$260.0m$211.0m$201.0m$335.0m$284.0m
Total assets$6.65bn$6.56bn$6.64bn$6.18bn$6.09bn$6.18bn$6.30bn$6.01bn
Cash and short-term investments$1.17bn$1.16bn$1.63bn$1.28bn$1.16bn$1.24bn$1.22bn$939.0m
Debt$582.0m$2.07bn$2.07bn$2.07bn$2.07bn$2.07bn$2.07bn$2.06bn
Shareholders' equity$2.84bn$2.68bn$2.72bn$2.38bn$2.26bn$2.37bn$2.37bn$2.13bn

Financial ratios

Data as of 28 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin66.7%65.4%60.9%64.8%69.7%68.0%
Operating margin19.9%-19.1%-23.7%-91.2%-2.7%12.1%
Net margin19.6%-28.0%-25.8%-96.1%16.8%20.3%
Return on equity31.2%-51.5%-20.2%-66.7%7.1%14.0%
Return on assets12.8%-19.4%-11.5%-35.9%5.0%8.6%
Free cash flow yield3.0%2.2%1.6%1.6%1.8%3.2%
Revenue growth-0.8%-2.9%-1.7%1.3%39.7%-8.6%
Earnings growth-169.5%5.3%-73.6%-678.0%16.2%-34.5%
Current ratio2.08x1.78x1.66x1.28x2.48x3.60x
Debt to equity0.76x0.87x0.27x0.43x0.16x0.26x
Equity ratio41.0%37.6%56.8%53.9%70.6%61.9%
Interest coverage8.55x-8.33x-13.88x-160.73x-2.02x8.02x
R&D as a share of sales21.9%26.7%30.1%28.8%26.2%21.1%
Buybacks as a share of market value3.8%-0.6%-0.6%-0.6%-6.8%0.7%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.8%6.0%6.9%
Operating income—17.1%3.5%
Net income—5.3%6.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin66.1%64.4%65.8%66.9%
Operating margin0.4%-29.3%-19.4%-3.2%
Net margin-4.3%-33.4%-17.7%-2.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings23.8-17.5-18.5-7.076.280.647.652.643.339.8
Price to sales4.74.94.86.812.816.313.513.011.47.7

Market value over time

31 Oct 2016 to 25 Sept 2026, in USD

$19.58bn$41.31bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-3%-1%-27%-49%3%10%13%35%69%-29%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 2-for-1 split · 23 Sept 2008

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.